Enrolment in the study is being halted in response to the Independent Data Monitoring Committee’s recommendation. Shares of Dr Reddy’s Laboratories Ltd ended at ₹1,288.40, down by ₹30.35, or 2.30%, on the BSE today, March 13.
Enrolment in the study is being halted in response to the Independent Data Monitoring Committee’s recommendation. Shares of Dr Reddy’s Laboratories Ltd ended at ₹1,288.40, down by ₹30.35, or 2.30%, on the BSE today, March 13.